Most Recent
Qantas ordered to pay Perth Airport $9.5M in terminal fee dispute
Aviation 2022-03-04 11:58 am By Miklos Bolza

Qantas has been ordered to pay $9.5 million in unpaid fees after the Western Australia Supreme Court resolved a dispute over the “fair and reasonable” amount owed for terminal services provided for the airline’s domestic and international flights.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Settlement talks in Astora pelvic mesh class action ‘well advanced’
Product Liability 2022-03-03 9:57 pm By Miklos Bolza

Settlement talks in a class action brought by Shine Lawyers against Astora Women’s Health on behalf of women injured by allegedly defective pelvic mesh products are “well advanced”, while mediation in two similar actions is ongoing, a court has heard.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Corestaff to pay $6.4M to settle class action by Papua New Guinea workers
Class Actions 2022-03-02 12:22 pm By Cat Fredenburgh

Labour hire firm CoreStaff will pay $6.4 million to settle a class action accusing it of using the promise of long-term work to lure workers to Australia from Papua New Guinea, only to terminate their employment agreements less than three years after they made the move.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Abandoned IVF clinic merger no win for ACCC, judge says
Competition & Consumer Protection 2022-03-01 4:54 pm By Christine Caulfield

The ACCC got what it wanted when IVF providers Virtus Health and Healius terminated a proposed $45 million merger, but it wasn’t a win, a judge has said in mostly denying the regulator’s bid to recover the costs of its court challenge to the deal.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Juno found liable for infringing Pfizer’s Dynastat patent
Intellectual Property 2022-03-01 6:06 pm By Miklos Bolza

A judge has found Pfizer’s patent for its post-operative injectable painkiller Dynastat is valid and that Australian drug maker Juno Pharmaceuticals infringed the patent by selling generic versions of the drug in Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Insurers defeat appeals in COVID-19 business interruption test cases
COVID-19 2022-02-21 5:11 pm By Christine Caulfield

An appeals court challenge by a group of small businesses seeking coverage under business interruption insurance policies for losses flowing from COVID-19 restrictions has largely failed.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Blue Star Helium’s former boss appeals ban over ill-fated Texas oil asset sale
Energy & Natural Resources 2022-02-07 2:04 pm By Christine Caulfield

The former CEO of Blue Star Helium is challenging a ruling that slugged him with a $40,000 penalty and a four-year ban for failing to disclose to shareholders the identify of the buyer behind a botched sale of Texas oil assets.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

DLA Piper appoints acclaimed real estate partner from Moray & Agnew
Real Estate 2022-01-28 11:16 pm By Bianca Hrovat

Law firm DLA Piper has picked up a pre-eminent property partner from Moray & Agnew, who advised on the $175 million joint venture between GPT and QuadReal Property Ground to acquire logistics developments on Australia’s eastern seaboard. On Monday, Sallie Bowtell was appointed to DLA Piper’s real estate practice in Melbourne, where the team’s head,…

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

CoreStaff settles class action accusing it of misleading Papua New Guinea workers
Class Actions 2022-01-21 10:54 am By Cat Fredenburgh

Labour on-hire and recruitment company CoreStaff has settled a class action alleging it lured workers to Australia from Papua New Guinea with the promise of long-term work, only to terminate their employment agreements less than three years after they relocated.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

‘Inherently implausible’: Generic Partners loses fight with Neurim over melatonin drug patent
Intellectual Property 2022-01-20 2:59 pm By Cindy Cameronne

Israeli drug company Neurim Pharmaceuticals has won an eight month extension to apply for a grace period for its melatonin tablet patent to treat children with autism spectrum disorder after Australian company Generic Partners lost its “inherently implausible” opposition to the patent.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?